4//SEC Filing
Evans John M. 4
Accession 0000950170-24-111732
CIK 0001745999other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:49 PM ET
Size
6.1 KB
Accession
0000950170-24-111732
Insider Transaction Report
Form 4
Evans John M.
DirectorCEO
Transactions
- Sale
Common Stock
2024-09-30$24.60/sh−60,000$1,476,024→ 938,659 total
Holdings
- 103,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]These shares of common stock were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.26 to $25.24, inclusive. The Reporting Person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Includes 316 shares acquired by the Reporting Person under the BEAM Amended and Restated 2019 Employee Stock Purchase Plan on September 30, 2024.
Documents
Issuer
Beam Therapeutics Inc.
CIK 0001745999
Entity typeother
Related Parties
1- filerCIK 0001786304
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 5:49 PM ET
- Size
- 6.1 KB